AzTrials
AzTrials

HealthyNCT03752229

Capillary Blood Volume and Pain Perception Obtained in a Process of Puncturing With Different Safety Lancets

A study testing Acti-Lance Lite, Acti-Lance Universal and Acti-Lance Special in people with Healthy, run by HTL-Strefa S.A. at 1 site in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study was a randomized, single blind, uni-center pivotal study in male and female healthy volunteers, to determine capillary blood volume and pain perception obtained in a process of puncturing with different safety lancets. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Acti-Lance Lite, Acti-Lance Universal and Acti-Lance Special
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 sitePoland
Study dates
8 Dec 2017to 30 Jan 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Willing to sign the informed consent.
  • Male and female volunteers
  • Age between 18 and 65 inclusive
  • Able to communicate well with the Investigator and comply with the requirements of the study
  • Volunteers who are in good physical and mental health

Who cannot join

  • Confirmed or suspected malignant cancer
  • Pregnancy or breastfeeding (only for women with childbearing potential based on pregnancy test conducted at Site)
  • History of poor blood circulation.
  • Any skin condition on his or her fingers that prevents blood sampling
  • Anxiety with needles or finger pricks
  • Clotting disorders (including bleeding) in medical history
Show all 14Show fewer
  • Neuropathy or other condition affecting sensation in the hands.
  • History of blood borne infection (e.g., HIV, hepatitis B or C, syphilis, malaria, babesiosis, brucellosis, leptospirosis, arboviral infections, relapsing fever, T lymphotropic virus Type 1, Creutzfeldt-Jakob disease)
  • Currently participating in another study
  • History of drug or alcohol abuse within the 12 months prior to screening or evidence of such abuse
  • Intake of alcohol within 48 hours prior to the start of the study (self-reporting)
  • Donation or loss of 400 mL or more of blood within 4 weeks prior to the start of the study
  • Any other condition that in the Investigator opinion may negatively influence Subject's participation in the study
  • Intake of medicines that affect blood coagulability (including anticoagulants such as vitamin K, antivirals and anticoagulants such as heparin, aspirin, thrombin inhibitors, vitamin K antagonists).

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • BioResearch Group Sp. z o.o.

    Nadarzyn, Masovian Voivodeship, 05-830

Other trials in Poland

About this study

Official title: A Randomized, Single Blind, Uni-centre Study in Healthy Volunteers, to Determine Capillary Blood Volume and Pain Perception Obtained in a Process of Puncturing With Different Safety Lancets

The study was a randomized, single blind, uni-center pivotal study in male and female healthy volunteers, to determine capillary blood volume and pain perception obtained in a process of puncturing with different safety lancets.

A group of three hundred (300) Caucasian male and female Subjects was randomized (aged > 18 to < 65 years old) who were in good physical and mental condition. The Subjects had 4 (four) fingers (two fingers from each hand) lanced each with a different type of safety lancet. Overall, 4 (four) different safety lancets were investigated per each Subject.

Overall, 48 (forty eight) different safety lancets (4 different safety lancets per one Subject) were investigated, the capillary blood volume and pain were measured.

Conditions
Healthy
Being tested
Acti-Lance Lite, Acti-Lance Universal, Acti-Lance Special, Medlance Plus Super Lite, Medlance Plus Lite
Keywords
safety lancets, lancet, capillary blood, capillary blood sampling, blood volume, pain
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acti-Lance LiteDevice

    Also called HTL-STREFA S.A. safety lancet type 610

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Acti-Lance UniversalDevice

    Also called HTL-STREFA S.A. safety lancet type 610

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Acti-Lance SpecialDevice

    Also called HTL-STREFA S.A. safety lancet type 610

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance Plus Super LiteDevice

    Also called HTL-STREFA S.A. safety lancet type 553

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance Plus LiteDevice

    Also called HTL-STREFA S.A. safety lancet type 553

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance Plus UniversalDevice

    Also called HTL-STREFA S.A. safety lancet type 554

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance Plus ExtraDevice

    Also called HTL-STREFA S.A. safety lancet type 555

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance Plus SpecialDevice

    Also called HTL-STREFA S.A. safety lancet type 556

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Prolance Micro FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 430

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Prolance Low FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 430

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Prolance Normal FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 430

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Prolance High FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 430

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Prolance Max FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 430

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Prolance PediatricDevice

    Also called HTL-STREFA S.A. safety lancet type 430

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Haemolance Micro FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 420

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Haemolance Low FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 420

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Haemolnace Normal FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 420

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Haemolance High FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 420

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Haemolance Max FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 420

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Haemolance PediatricDevice

    Also called HTL-STREFA S.A. safety lancet type 420

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • MediSafe Solo 29 GaugeDevice

    Also called HTL-STREFA S.A. safety lancet type 520

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • MediSafe Solo 23 GaugeDevice

    Also called HTL-STREFA S.A. safety lancet type 520

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • ergoLance Micro FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 450

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • ergoLance Normal FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 450

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • ergoLance High FlowDevice

    Also called HTL-STREFA S.A. safety lancet type 450

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance (light blue)Device

    Also called HTL-STREFA S.A. safety lancet type 545

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance (blue)Device

    Also called HTL-STREFA S.A. safety lancet type 545

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance (dark blue)Device

    Also called HTL-STREFA S.A. safety lancet type 546

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance (yellow)Device

    Also called HTL-STREFA S.A. safety lancet type 547

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance (orange)Device

    Also called HTL-STREFA S.A. safety lancet type 548

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Medlance (red)Device

    Also called HTL-STREFA S.A. safety lancet type 549

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Unistik 3 ExtraDevice

    Also called Owem Mumford lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Unistik 3 ComfortDevice

    Also called Owem Mumford lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Unistik TouchDevice

    Also called Owem Mumford lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • ReadyLance (blue)Device

    Also called Medicore lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • ReadyLance (orange)Device

    Also called Medicore lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • AssureLanceDevice

    Also called Arkray lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • AssureLance MicroFlowDevice

    Also called Arkray lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • SurgilanceDevice

    Also called Medipurpose lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Surgilance Lite (grey)Device

    Also called Medipurpose lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • Surgilance Lite (purple)Device

    Also called Medipurpose lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • SteriLance Lite2Device

    Also called Sterilance lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • SensiLance (pink)Device

    Also called Dynarex lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • SteriLance PressDevice

    Also called Sterilance lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • SensiLance (orange)Device

    Also called Dynarex lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • mylifeDevice

    Also called Ypsomed lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • VeriFineDevice

    Also called Promismed lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

  • MicrodotDevice

    Also called Cambridge Sensors lancet

    Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

    Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler.

Study groups in NCT03752229
Study groupRoleWhat they receive
HTL-STREFA S.A.safety lancet type 610ExperimentalNot described
Receives: Device: Acti-Lance Lite; Device: Acti-Lance Universal; Device: Acti-Lance Special
HTL-STREFA S.A.safety lancet type 553-556ExperimentalNot described
Receives: Device: Medlance Plus Super Lite; Device: Medlance Plus Lite; Device: Medlance Plus Universal; Device: Medlance Plus Extra; Device: Medlance Plus Special
HTL-STREFA S.A.safety lancet type 430ExperimentalNot described
Receives: Device: Prolance Micro Flow; Device: Prolance Low Flow; Device: Prolance Normal Flow; Device: Prolance High Flow; Device: Prolance Max Flow; Device: Prolance Pediatric
HTL-STREFA S.A.safety lancet type 420ExperimentalNot described
Receives: Device: Haemolance Micro Flow; Device: Haemolance Low Flow; Device: Haemolnace Normal Flow; Device: Haemolance High Flow; Device: Haemolance Max Flow; Device: Haemolance Pediatric
HTL-STREFA S.A.safety lancet type 520ExperimentalNot described
Receives: Device: MediSafe Solo 29 Gauge; Device: MediSafe Solo 23 Gauge
HTL-STREFA S.A.safety lancet type 450ExperimentalNot described
Receives: Device: ergoLance Micro Flow; Device: ergoLance Normal Flow; Device: ergoLance High Flow
HTL-STREFA S.A.safety lancet type 545-549ExperimentalNot described
Receives: Device: Medlance (light blue); Device: Medlance (blue); Device: Medlance (dark blue); Device: Medlance (yellow); Device: Medlance (orange); Device: Medlance (red)
Owem Mumford lancetExperimentalNot described
Receives: Device: Unistik 3 Extra; Device: Unistik 3 Comfort; Device: Unistik Touch
Medicore lancetExperimentalNot described
Receives: Device: ReadyLance (blue); Device: ReadyLance (orange)
Arkray lancetExperimentalNot described
Receives: Device: AssureLance; Device: AssureLance MicroFlow
Medipurpose lancetExperimentalNot described
Receives: Device: Surgilance; Device: Surgilance Lite (grey); Device: Surgilance Lite (purple)
Sterilance lancetExperimentalNot described
Receives: Device: SteriLance Lite2; Device: SteriLance Press
Dynarex lancetExperimentalNot described
Receives: Device: SensiLance (pink); Device: SensiLance (orange)
Ypsomed lancetExperimentalNot described
Receives: Device: mylife
Promismed lancetExperimentalNot described
Receives: Device: VeriFine
Cambridge Sensors lancetExperimentalNot described
Receives: Device: Microdot

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Volume (microliters) of blood in the capillary tube

    The amount of capillary blood volume collected after a single lancing of the fingertip.

    Measured: The blood volume was noted after 20 seconds

  2. Volume (microliters) of blood in the capillary tube

    The amount of capillary blood volume collected after a single lancing of the fingertip.

    Measured: The blood volume was noted until the end of bleeding or up to 2 minutes time

Secondary outcomes (2)
  1. Pain perception

    The intensity of pain perceived by the patient was assessed with the use of the numeric Visual Analog Scale (VAS). The Subject marked on the scale the number from 0 ("no pain") to 10 ("worst imaginable pain") that represented their perception of pain. A higher score indicated greater pain intensity.

    Measured: directly after lancing

  2. Pain perception

    The intensity of pain perceived by the patient was assessed with the use of the numeric Visual Analog Scale (VAS). The Subject marked on the scale the number from 0 ("no pain") to 10 ("worst imaginable pain") that represented their perception of pain. A higher score indicated greater pain intensity.

    Measured: after 30 minutes ± 5 min after lancing

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Nov 2018
  2. Study start8 Dec 2017
  3. Primary completion17 Dec 2017
  4. Study completion30 Jan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03752229
Sponsor's protocol ID
02LAN2017
Status last verified
Nov 2018
First submitted
20 Nov 2018
Last updated
26 Nov 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Acti-Lance Lite, Acti-Lance Universal and Acti-Lance Special in people with Healthy, run by HTL-Strefa S.A. at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Volume (microliters) of blood in the capillary tube (time frame: The blood volume was noted after 20 seconds). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in